WAVETRONICA BV

Their core work

WaveTronica BV is a Dutch technology SME specializing in radiofrequency (RF) antenna and coil engineering for medical MRI systems. Their core capability is designing RF hardware that enables advanced in-vivo metabolic imaging — specifically the kind of antennas needed to detect low-sensitivity nuclei like deuterium inside the human body during MRI scans. In the H2020 portfolio they contributed RF antenna technology to two consecutive FET projects targeting clinical metabolic imaging: one focused on predicting chemotherapy efficacy in cancer patients, the other on mapping whole-body biochemistry. They occupy a narrow but technically critical niche between RF electronics and clinical MRI instrumentation.

What they specialise in

How they've shifted over time

Both H2020 projects ran simultaneously in the 2019–2021 window, meaning there is no temporal evolution visible in this dataset — WaveTronica entered the H2020 programme with a fully formed focus on RF antennas for metabolic MRI and stayed within that niche throughout. No keyword data is available to trace finer shifts in emphasis. Given the technical depth implied by both projects, their expertise likely predates H2020 participation and was already mature by the time they joined these FET consortia.

WaveTronica appears to be a deep specialist in a single high-value niche — RF hardware for emerging MRI metabolic imaging — and shows no signs of diversifying, making them a reliable but narrow collaborator for future MRI instrumentation or clinical imaging projects.

How they like to work

WaveTronica has never led an H2020 project, always joining as a participant, which is consistent with a small specialist SME that brings hardware know-how rather than project management capacity. Their consortium footprint is minimal — just 3 unique partners across 2 countries — suggesting they prefer tightly scoped technical partnerships over broad multi-partner networks. For a potential collaborator, this means you get focused RF engineering input, but should not expect them to carry administrative or coordination load.

WaveTronica has collaborated with only 3 unique partners across 2 countries, both projects likely sharing overlapping consortium members given the same funding period and thematic overlap. Their network is narrow and geographically concentrated, consistent with a small Dutch SME embedded in a specific academic-industrial MRI research cluster.

What sets them apart

WaveTronica occupies a rare position as a commercial SME with deep RF hardware expertise applied specifically to emerging metabolic MRI — a field where most players are academic labs or large MRI manufacturers. For a consortium building a clinical metabolic imaging project, they offer something hard to find: a small company that can actually produce and iterate on specialized RF coil hardware outside of Philips or Siemens. Their FET-track record also signals comfort operating at the frontier of MRI science rather than in routine clinical engineering.

Highlights from their portfolio

• MIRACLE
  The largest of their two projects (EUR 62,500) targets a high-impact clinical problem — predicting whether chemotherapy is working — using RF antenna-enabled metabolic MRI, placing WaveTronica directly in the oncology diagnostics space.
• BodyDMI
  Focuses on whole-body deuterium metabolic imaging, a technically demanding frontier application that requires custom RF hardware and positions WaveTronica at the edge of what current MRI systems can achieve.